About
Technology
Issues
FAQ
Links
Official Page
Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004–2015
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.